Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Paratek Pharmaceuticals

    - PMLiVE

    Scientists uncover new drug target in fight against antimicrobial resistance

    The discovery could lead to improved treatments for bacterial infections

    - PMLiVE

    GSK’s antibiotic Blujepa granted FDA approval to treat urinary tract infections

    Blujepa is the first in a new class of oral antibiotics for uncomplicated UTIs in nearly 30 years

    - PMLiVE

    Paratek announces positive late-stage results for Nuzyra in bacterial pneumonia

    The condition, caused by various bacteria, affects more than 900,000 people in the US every year

    - PMLiVE

    WHO publishes latest report on development of antibacterial agents worldwide

    AMR is designated as one of the top ten global public health threats facing humanity

    - PMLiVE

    MIT protein study could help accelerate development of new antibiotics

    Histidine kinase is a crucial bacterial protein that regulates processes, including antibiotic resistance

    - PMLiVE

    WHO reveals ‘extensive’ worldwide overuse of antibiotics during COVID-19 pandemic

    Findings from the report reveal factors that could have contributed to the spread of antimicrobial resistance

    - PMLiVE

    NHS launches plans to expand drug contracts to develop new life-saving antibiotics

    New antibiotics could reduce death rates and ensure future pandemic preparedness

    - PMLiVE

    EU outlines measures to mitigate antibiotic shortage across Europe

    An unseasonably early upsurge in respiratory infections has led to the increase in demand

    - PMLiVE

    EU to revise pharmaceuticals law amid antibiotic shortages

    The early upsurge in respiratory infections has led to a sudden increase in demand for antibiotics

    - PMLiVE

    GSK to submit drug application for new antibiotic to US FDA

    Gepotidacin could be the first new novel oral antibiotic treatment for uncomplicated urinary tract infections in over 20 years

    - PMLiVE

    Merck and Bill & Melinda Gates Institute sign licensing agreement for tuberculosis candidates

    The non-profit will determine their potential for inclusion in new affordable treatment regimens

    - PMLiVE

    Sandoz completes acquisition of GSK’s cephalosporin business

    The acquisition confirms Sandoz’ commitment to antibiotics, following the announcement of further investment plans for European-based manufacturing network

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links